Moitri Roy is a Senior Scientist and lead in Bioanalytical development at SalioGen Therapeutics, where they focus on bioassay advancements and molecular biology. With over five years of experience in biotech firms, including bluebird bio and Beam Therapeutics, Moitri has specialized in potency assays and analytical development. Their previous roles include Associate Scientist positions at Intellia Therapeutics and bluebird bio, and they hold multiple degrees in microbiology and molecular biology, showcasing a strong commitment to scientific excellence and innovation in gene therapy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices